Annual D&A
$24.36 M
+$974.00 K+4.17%
31 December 2023
Summary:
Harmony Biosciences Holdings annual depreciation & amortization is currently $24.36 million, with the most recent change of +$974.00 thousand (+4.17%) on 31 December 2023. During the last 3 years, it has risen by +$14.12 million (+137.95%). HRMY annual D&A is now at all-time high.HRMY Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$5.97 M
-$84.00 K-1.39%
30 September 2024
Summary:
Harmony Biosciences Holdings quarterly depreciation & amortization is currently $5.97 million, with the most recent change of -$84.00 thousand (-1.39%) on 30 September 2024. Over the past year, it has dropped by -$138.00 thousand (-2.26%). HRMY quarterly D&A is now -2.56% below its all-time high of $6.13 million, reached on 31 December 2023.HRMY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$24.27 M
-$138.00 K-0.57%
30 September 2024
Summary:
Harmony Biosciences Holdings TTM depreciation & amortization is currently $24.27 million, with the most recent change of -$138.00 thousand (-0.57%) on 30 September 2024. Over the past year, it has dropped by -$33.00 thousand (-0.14%). HRMY TTM D&A is now -0.61% below its all-time high of $24.42 million, reached on 31 March 2024.HRMY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRMY Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.2% | -2.3% | -0.1% |
| 3 y3 years | +137.9% | +27.7% | +31.4% |
| 5 y5 years | +10000.0% | +466.8% | +1818.5% |
HRMY Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +137.9% | -2.6% | +27.7% | -0.6% | +31.4% |
| 5 y | 5 years | at high | >+9999.0% | -2.6% | +466.8% | -0.6% | +1818.5% |
| alltime | all time | at high | >+9999.0% | -2.6% | +6605.6% | -0.6% | >+9999.0% |
Harmony Biosciences Holdings Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.97 M(-1.4%) | $24.27 M(-0.6%) |
| June 2024 | - | $6.05 M(-1.2%) | $24.41 M(-0.0%) |
| Mar 2024 | - | $6.12 M(-0.0%) | $24.42 M(+0.2%) |
| Dec 2023 | $24.36 M(+4.2%) | $6.13 M(+0.3%) | $24.36 M(+0.2%) |
| Sept 2023 | - | $6.11 M(+0.7%) | $24.30 M(+0.2%) |
| June 2023 | - | $6.06 M(0.0%) | $24.26 M(+0.0%) |
| Mar 2023 | - | $6.06 M(-0.1%) | $24.25 M(+3.7%) |
| Dec 2022 | $23.39 M(+24.1%) | $6.07 M(+0.1%) | $23.39 M(+5.9%) |
| Sept 2022 | - | $6.06 M(+0.1%) | $22.08 M(+6.7%) |
| June 2022 | - | $6.05 M(+16.5%) | $20.69 M(+6.8%) |
| Mar 2022 | - | $5.20 M(+9.2%) | $19.36 M(+2.8%) |
| Dec 2021 | $18.84 M | $4.76 M(+1.9%) | $18.84 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $4.67 M(-1.2%) | $18.46 M(+17.2%) |
| June 2021 | - | $4.73 M(+1.1%) | $15.76 M(+20.9%) |
| Mar 2021 | - | $4.68 M(+6.8%) | $13.03 M(+27.3%) |
| Dec 2020 | $10.24 M(+218.9%) | $4.38 M(+122.8%) | $10.24 M(+31.3%) |
| Sept 2020 | - | $1.97 M(-1.8%) | $7.80 M(+13.3%) |
| June 2020 | - | $2.00 M(+6.4%) | $6.88 M(+37.6%) |
| Mar 2020 | - | $1.88 M(-3.2%) | $5.00 M(+55.9%) |
| Dec 2019 | $3.21 M(+1644.6%) | $1.95 M(+84.7%) | $3.21 M(+153.8%) |
| Sept 2019 | - | $1.05 M(+756.1%) | $1.26 M(+496.7%) |
| June 2019 | - | $123.00 K(+38.2%) | $212.00 K(+138.2%) |
| Mar 2019 | - | $89.00 K | $89.00 K |
| Dec 2018 | $184.00 K | - | - |
FAQ
- What is Harmony Biosciences Holdings annual depreciation & amortization?
- What is the all time high annual D&A for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual D&A year-on-year change?
- What is Harmony Biosciences Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly D&A year-on-year change?
- What is Harmony Biosciences Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings TTM D&A year-on-year change?
What is Harmony Biosciences Holdings annual depreciation & amortization?
The current annual D&A of HRMY is $24.36 M
What is the all time high annual D&A for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual depreciation & amortization is $24.36 M
What is Harmony Biosciences Holdings annual D&A year-on-year change?
Over the past year, HRMY annual depreciation & amortization has changed by +$974.00 K (+4.17%)
What is Harmony Biosciences Holdings quarterly depreciation & amortization?
The current quarterly D&A of HRMY is $5.97 M
What is the all time high quarterly D&A for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly depreciation & amortization is $6.13 M
What is Harmony Biosciences Holdings quarterly D&A year-on-year change?
Over the past year, HRMY quarterly depreciation & amortization has changed by -$138.00 K (-2.26%)
What is Harmony Biosciences Holdings TTM depreciation & amortization?
The current TTM D&A of HRMY is $24.27 M
What is the all time high TTM D&A for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high TTM depreciation & amortization is $24.42 M
What is Harmony Biosciences Holdings TTM D&A year-on-year change?
Over the past year, HRMY TTM depreciation & amortization has changed by -$33.00 K (-0.14%)